Recently, Nishikawa et al. [83] recommended combined evaluation of the expression levels of potential markers in the mTOR signaling pathway, which would contribute to the accurate prediction of disease recurrence following nephrectomies in RCC cases. The gene discussed is MTOR; the disease is renal cell carcinoma.